Erratum: In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: First results from Turkey (Environ Monit Assess (DOI 10.1007/s10661-009-1293-y));In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: First results from Turkey

Environmental Monitoring and Assessment

Volumn 171, Issue 1-4, 2010, Pages 487-491

  Erdogan, Haluk ^a   Can, Fusun ^a   Demirbilek, Muge ^a   Timurkaynak, Funda ^a   Arslan, Hande ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Antimicrobial resistance surveillance; Legionella pneumophila; Legionnaires' disease

Indexed keywords

ANTIBIOTICS; ESCHERICHIA COLI; WATERWORKS;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL RESISTANCES; ENVIRONMENTAL WATER SYSTEMS; LEGIONELLA PNEUMOPHILA; LEGIONELLA SPECIES; LEGIONELLA SPP; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL AGENTS;

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; RIFAMPICIN; WATER;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CONCENTRATION (COMPOSITION); DILUTION; INHIBITION; WATER SUPPLY; WATER TREATMENT;

ANTIBIOTIC SENSITIVITY; AQUATIC ENVIRONMENT; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; LEGIONELLA; LEGIONELLA PNEUMOPHILA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC);

TURKEY;

ESCHERICHIA COLI; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEGIONELLA PNEUMOPHILA SEROGROUP 1; LEGIONELLA PNEUMOPHILA SEROGROUP 3; LEGIONELLA PNEUMOPHILA SEROGROUP 6; STAPHYLOCOCCUS AUREUS;

EID: 78149413786     PISSN: 01676369     EISSN: 15732959     Source Type: Journal    
DOI: 10.1007/s10661-010-1356-0     Document Type: Erratum

References (16)

1. JE Barker ID Farrell 1990 The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies Journal of Antimicrobial Chemotherapy 26 45 53 1:CAS:528:DyaK3cXlsVykurc%3D 10.1093/jac/26.1.45
2. RM Blázquez Garrido FJ Espinosa Parra L Alemany Francés RM Ramos Guevara JM Sánchez-Nieto M Segovia Hernández, et al. 2005 Antimicrobial chemotherapy for Legionnaires disease: Levofloxacin versus macrolides Clinical Infectious Diseases 40 800 806 10.1086/428049 (Pubitemid 40365497)
3. IA Critchley ME Jones PD Heinze D Hubbard HD Engler AT Evangelista, et al. 2002 In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe Clinical Microbiology and Infection 8 214 221 1:CAS:528:DC%2BD38XkvVymsbg%3D 10.1046/j.1469-0691.2002.00392.x (Pubitemid 34993788)
4. J Dubois C St-Pierre 1999 In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species Diagnostic Microbiology and Infectious Disease 33 261 265 1:CAS:528:DyaK1MXivVSqtrg%3D 10.1016/S0732-8893(98)00150-3 (Pubitemid 29142366)
5. LM Dunbar DJ Farrell 2007 Activity of telithromycin and comparators against isolates of Legionella pneumophila collected from patients with community-acquired respiratory tract infections: PROTEKT years 1-5 Clinical Microbiology and Infection 13 743 746 1:CAS:528:DC%2BD2sXotlSht7s%3D 10.1111/j.1469-0691.2007.01717.x (Pubitemid 46909357)
6. PH Edelstein 1991 Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: Study of rifampin resistance using a guinea pig model of Legionnaires disease Antimicrobial Agents and Chemotherapy 35 5 9 1:CAS:528:DyaK3MXnsVOluw%3D%3D
7. H Erdogan H Arslan 2007 Colonization of Legionella species in hotel water systems in Turkey Journal of Travel Medicine 14 369 373 10.1111/j.1708-8305. 2007.00146.x (Pubitemid 350077370)
8. MT García C Pelaz MJ Giménez L Aguilar 2000 In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: Influence of charcoal on susceptibility test results Antimicrobial Agents and Chemotherapy 44 2176 2178 10.1128/AAC.44.8.2176-2178.2000 (Pubitemid 30484446)
9. R Gómez-Lus F Adrián R del Campo P Gómez-Lus S Sánchez C García, et al. 2001 Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp International Journal of Antimicrobial Agents 18 49 54 10.1016/S0924-8579(01)00339-9
10. LA Mandell RG Wunderink A Anzueto JG Bartlett GD Campbell NC Dean 2007 Infectious diseases society of America; American thoracic society Clinical Infectious Diseases 44 27 72 10.1086/511159 (Pubitemid 46290553)
11. L Pedro-Botet VL Yu 2006 Legionella: Macrolides or quinolones? Clinical Microbiology and Infection 12 25 30 1:CAS:528:DC%2BD28XlsFCgsbs%3D 10.1111/j.1469-0691.2006.01394.x
12. C Reda T Quaresima MC Pastoris 1994 In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin Journal of Antimicrobial Chemotherapy 33 757 764 1:CAS:528:DyaK2cXlsFeisLg%3D 10.1093/jac/33.4.757
13. J Roig J Rello 2003 Legionnaires' disease: A rational approach to therapy Journal of Antimicrobial Chemotherapy 51 1119 1129 1:CAS:528: DC%2BD3sXjsVKls7Y%3D 10.1093/jac/dkg191 (Pubitemid 36622068)
14. JE Stout K Sens S Mietzner A Obman VL Yu 2005 Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing International Journal of Antimicrobial Agents 25 302 307 1:CAS:528:DC%2BD2MXisFGktL4%3D 10.1016/j.ijantimicag.2004.08.019 (Pubitemid 40387275)
15. JE Stout VL Yu 1997 Legionellosis New England Journal of Medicine 337 682 687 1:STN:280:DyaK2svgslyntA%3D%3D 10.1056/NEJM199709043371006 (Pubitemid 27375476)
16. A Tsakris S Alexiou-Daniel E Souliou A Antoniadis 1999 In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems Journal of Antimicrobial Chemotherapy 44 693 695 1:CAS:528:DyaK1MXnsFSjt70%3D 10.1093/jac/44.5.693 (Pubitemid 29532850)